Sign up to read this article for FREE!
After signing up, you'll start to receive regular news updates from us.
New Results Reveal Competitive Advantages of VitroGrow™ Stem Cell Culture Media
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Vitro Diagnostics, Inc. has announced completion of studies comparing its mesenchymal stem cell culture media, VitroGrow™, to major competitors showing distinct performance improvements over competing products.
These new results showed that VitroGrow™ consistently improved mesenchymal stem cell growth, quality, potency and cellular recovery over leading competitors including comparable products sold by InVitrogen, Lonza and Stem Cell Technologies.
Furthermore, VitroGrow™ also exhibits real-time stability that exceeds 1 year while competitors published recommended usage periods are 2 weeks to 4 weeks, thus resulting in substantial cost savings and expanded usage opportunities to VitroGrow™ customers.
These new results showed that VitroGrow™ consistently improved mesenchymal stem cell growth, quality, potency and cellular recovery over leading competitors including comparable products sold by InVitrogen, Lonza and Stem Cell Technologies.
Furthermore, VitroGrow™ also exhibits real-time stability that exceeds 1 year while competitors published recommended usage periods are 2 weeks to 4 weeks, thus resulting in substantial cost savings and expanded usage opportunities to VitroGrow™ customers.
